01107nam0 22002651i 450 UON0027733520231205103822.19020060522d1979 |0itac50 bahinIN|||| 1||||Ilacandra joshi ke aupnyasik nayak ka antardundu pramuk upanyasom ke samdarm memRajendra JainDilliSurya prakashan1979112 p.19 cmLETTERATURA HINDICRITICASEC. XXUONC005913FIINNew DelhiUONL000110SI VI CASUBCONT. INDIANO - LETTERATURA HINDI - CRITICAAJAINRajendraUONV160799691990Surya PrakashanaUONV255936650ITSOL20240220RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00277335SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI SI VI CA 551 N SI SA 35697 5 551 N Ilacandra joshi ke aupnyasik nayak ka antardundu pramuk upanyasom ke samdarm mem1243041UNIOR04431nam 2201333z- 450 9910404084403321202102123-03928-759-1(CKB)4100000011302294(oapen)https://directory.doabooks.org/handle/20.500.12854/61309(oapen)doab61309(EXLCZ)99410000001130229420202102d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierTreatment Strategies and Survival Outcomes in Breast CancerMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (264 p.)3-03928-758-3 Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival.Medicine and Nursingbicsscabemaciclibadvanced breast canceranthracycline resistanceantihormone therapyAPOBEC3Baromatase inhibitorsATMbasal-like breast cancerbiomarkerBRCAbreast cancerBreast Cancerbreast cancer survivorsbreast-conserving therapycancer treatmentcell-free DNACHEK2chemotherapycirculating tumor cellscMetcolorectal cancercomparative effectivenesscontralateral breast cancercontralateral prophylactic mastectomycyclin Edisease-free survivalductal carcinoma in situEndocrine therapyERCC1exercise characteristicsfamily historyfulvestrantgene expressiongeriatric oncologyHDAC5 inhibitorsHER2 c-erbB2HER2/neuhistone deacetylaseincidenceinfiltrating breast cancerinvasive breast cancerlactate dehydrogenaselapatinibLDHliquid biopsyLKB1LMK-235lymph-node ratiomammography screeningmastectomymetastaticmetastatic breast cancerMetforminmonitoring metastatic breast cancermutation carriersn/aNCDBnext-generation sequencingolder patientsOlder womenoutcomeoverdiagnosisPALB2palbociclibpertuzumabphysical activityphysical functionPIK3CAprognosisradiotherapyrelative survivalribociclibSEERserum biomarkersocial well-beingSrc kinasestage IVsurvivalT-DM1taxane sensitivitytrastuzumabtumor biologyyoung womenzero-inflated Poisson regression modelMedicine and NursingCheung Kwok-Leungauth1325396BOOK9910404084403321Treatment Strategies and Survival Outcomes in Breast Cancer3036843UNINA